Dr. Rocío García Carbonero is a medical oncologist associated with Hospital Universitario 12 de Octubre in Madrid, Spain. The hospital identifies her as coordinator of its Digestive Tumors, Neuroendocrine Tumors, and Familial Cancer Unit. Her professional areas include medical oncology and the multidisciplinary management of gastrointestinal and neuroendocrine malignancies.

Medical Oncology and Professional Background

Medical oncology involves the assessment and treatment of cancer using systemic therapies. Depending on the cancer type and stage, treatment may include chemotherapy, targeted therapy, immunotherapy, hormone-based medicines, or other individualized approaches.

Dr. García Carbonero is associated with the Medical Oncology Department at Hospital Universitario 12 de Octubre. The hospital's oncology department provides outpatient and inpatient services, supportive oncology care, clinical trials, and specialist consultations. Its academic program includes medical education and research activities.

The hospital also lists Dr. García Carbonero among its medical oncology faculty, with an academic teaching role at the Complutense University of Madrid.

Gastrointestinal Oncology

Gastrointestinal oncology focuses on cancers affecting the digestive system, including the colon, rectum, stomach, esophagus, pancreas, liver, and other digestive organs.

Treatment depends on the location and stage of the tumor, its pathological characteristics, molecular findings, and the patient's general health. Medical oncologists work with surgeons, gastroenterologists, radiologists, pathologists, and radiation oncologists to evaluate treatment options.

For colorectal cancer, systemic treatment may be recommended before or after surgery or for advanced disease. The treatment plan may involve chemotherapy, targeted medicines, immunotherapy in selected cases, or participation in a clinical trial when appropriate.

For pancreatic and other digestive cancers, management depends on whether the tumor can be surgically removed, its stage, molecular features, and the patient's ability to tolerate treatment.

Neuroendocrine Tumors

Neuroendocrine tumors develop from cells with features of both nerve cells and hormone-producing cells. They can arise in different parts of the body, including the digestive tract and pancreas. These tumors vary considerably in their behavior, growth rate, and treatment requirements.

Evaluation may involve pathology review, imaging, laboratory tests, and other investigations selected according to the suspected tumor type. Treatment can include surgery, medication, targeted approaches, or other specialist therapies depending on tumor characteristics and disease extent.

Because neuroendocrine tumors can be complex, care often requires input from medical oncologists, surgeons, endocrinologists, radiologists, nuclear medicine specialists, and pathologists.

The hospital's official physician directory identifies Dr. García Carbonero as coordinator of the unit responsible for digestive and neuroendocrine tumors, as well as familial cancer.

Hospital Universitario 12 de Octubre

Hereditary and Familial Cancer

Familial cancer services evaluate patients whose personal or family history may indicate an inherited predisposition to cancer. Assessment can involve reviewing family history, identifying patterns of cancer occurrence, and considering genetic counseling or testing when clinically appropriate.

Genetic testing may help clarify whether an inherited variant contributes to cancer risk. Results can influence screening recommendations, prevention discussions, and treatment planning for certain cancers.

Not every patient with a family history of cancer has an inherited cancer syndrome. Genetic assessment should be guided by established clinical criteria and interpreted by qualified professionals.

Multidisciplinary Treatment and Research

Complex cancer care frequently involves collaboration between medical oncology, surgery, diagnostic imaging, pathology, genetics, and supportive care services.

Hospital Universitario 12 de Octubre organizes its Medical Oncology Department into specialist units according to tumor type. Its published directory identifies separate teams for breast and gynecological cancers, lung and thoracic tumors, genitourinary malignancies, digestive tumors, neuroendocrine tumors, and familial cancer.

The department also incorporates clinical trials and translational research into its services. Access to a clinical trial depends on the specific diagnosis, eligibility criteria, recruitment status, and the patient's medical circumstances.

Information for International Patients

Patients travelling to Madrid for digestive or neuroendocrine cancer evaluation should bring pathology reports, biopsy slides or blocks where available, CT or MRI scans, endoscopy reports, previous treatment records, laboratory results, and medication information.

Patients with suspected hereditary cancer may also wish to provide a relevant family history, including the types of cancer and approximate ages at diagnosis among relatives.

A specialist consultation can help determine whether further diagnostic testing, treatment planning, or referral to another discipline is appropriate. Treatment outcomes and eligibility for specific therapies cannot be guaranteed.

Dr. Rocío García Carbonero is listed by Hospital Universitario 12 de Octubre as coordinator of its Digestive Tumors, Neuroendocrine Tumors, and Familial Cancer Unit. Her profile is suitable for a medical tourism directory covering specialist gastrointestinal and neuroendocrine oncology in Spain.